News
Confo Therapeutics appoints Paolo Vicini as Chief Development Officer
- Details

Wellington Partners’s portfolio company Themis to be acquired by MSD
- Details

Themis collaborates with ABL Europe to manufacture its SARS-CoV-2 Vaccine Candidate in France
- Details
